Thursday, 9 August 2012

Sodium Chloride Inhalation Solution





Sodium Chloride Inhalation Solution 0.9% 3 mL


PRODUCT CODE 0378-6985-01


Sodium Chloride

Inhalation Solution

USP

0.9% 3 mL


For Respiratory Therapy


Not for parenteral administration.


3 mL, 100 Vials

Sterile

Unit-Dose Vial


Sodium Chloride Inhalation Solution USP

0.9% 3 mL


Sterile, non-pyrogenic, preservative-free single-use vials for respiratory therapy.

No bacteriostatic agent or other preservative added.


INDICATIONS: Contents of these vials are for use in respiratory therapy and for tracheal lavage.


WARNING: Not for injection or in preparations to be used for injection.


DIRECTIONS FOR USE: To verify container integrity, squeeze the vial before use. Twist cap completely off vial, invert and squeeze prescribed volume.


Discard any unused portion of the contents of this single-use vial as well as any unused solution remaining in the nebulizer cup.


HOW SUPPLIED: Single-use plastic vials containing 3 mL or 5 mL solutions supplied in cartons of 100 vials and 15 mL solution supplied in cartons of 50 vials.


PRODUCT CODE 0378-6985-01 Sodium Chloride Inhalation Solution USP 0.9%, 3 mL

PRODUCT CODE 0378-6986-01 Sodium Chloride Inhalation Solution USP 0.9%, 5 mL

PRODUCT CODE 0378-6987-89 Sodium Chloride Inhalation Solution USP 0.9%, 15 mL


Internal contents sterile. External surface of vial not sterile.


STORAGE: Store at controlled room temperature 15° to 30°C (59° to 86°F).


Rx Only


Manufactured by: Catalent, Woodstock, IL 60098 Distributed by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505


DYM:6985:100C:R2




Sodium Chloride Inhalation Solution 0.9% 5 mL


PRODUCT CODE 0378-6986-01


Sodium Chloride

Inhalation Solution

USP

0.9% 5 mL


For Respiratory Therapy


Not for parenteral administration.


5 mL, 100 Vials

Sterile

Unit-Dose Vial


Sodium Chloride Inhalation Solution USP

0.9% 5 mL


Sterile, non-pyrogenic, preservative-free single-use vials for respiratory therapy.

No bacteriostatic agent or other preservative added. 


INDICATIONS: Contents of these vials are for use in respiratory therapy and for tracheal lavage. 


WARNING: Not for injection or in preparations to be used for injection. 


DIRECTIONS FOR USE: To verify container integrity, squeeze the vial before use.

Twist cap completely off vial, invert and squeeze prescribed volume. 


Discard any unused portion of the contents of this single-use vial as well as any unused solution remaining in the nebulizer cup.


HOW SUPPLIED: Single-use plastic vials containing 3 mL or 5 mL solutions supplied in cartons of 100 vials and 15 mL solution supplied in cartons of 50 vials. 


PRODUCT CODE 0378-6985-01 Sodium Chloride Inhalation Solution USP 0.9%, 3 mL

PRODUCT CODE 0378-6986-01 Sodium Chloride Inhalation Solution USP 0.9%, 5 mL

PRODUCT CODE 0378-6987-89 Sodium Chloride Inhalation Solution USP 0.9%, 15 mL


Internal contents sterile. External surface of vial not sterile. 


STORAGE: Store at controlled room temperature 15° to 30°C (59° to 86°F).  


Rx Only


Manufactured by: Catalent, Woodstock, IL 60098 Distributed by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 


DYM:6986:100C:R2




Sodium Chloride Inhalation Solution 0.9% 15 mL


PRODUCT CODE 0378-6987-89


Sodium Chloride

Inhalation Solution

USP

0.9% 15 mL


For Respiratory Therapy


Not for parenteral administration.


15 mL, 50 Vials

Sterile

Unit-Dose Vial


Sodium Chloride Inhalation Solution USP

0.9% 15 mL


Sterile, non-pyrogenic, preservative-free single-use vials for respiratory therapy.

No bacteriostatic agent or other preservative added.


INDICATIONS: Contents of these vials are for use in respiratory therapy and for tracheal lavage.


WARNING: Not for injection or in preparations to be used for injection.


DIRECTIONS FOR USE: To verify container integrity, squeeze the vial before use. Twist cap completely off vial, invert and squeeze prescribed volume.


Discard any unused portion of the contents of this single-use vial as well as any unused solution remaining in the nebulizer cup.


HOW SUPPLIED: Single-use plastic vials containing 3 mL or 5 mL solutions supplied in cartons of 100 vials and 15 mL solution supplied in cartons of 50 vials.


PRODUCT CODE 0378-6985-01 Sodium Chloride Inhalation Solution USP 0.9%, 3 mL

PRODUCT CODE 0378-6986-01 Sodium Chloride Inhalation Solution USP 0.9%, 5 mL

PRODUCT CODE 0378-6987-89 Sodium Chloride Inhalation Solution USP 0.9%, 15 mL


Internal contents sterile. External surface of vial not sterile.


STORAGE: Store at controlled room temperature 15° to 30°C (59° to 86°F).


Rx Only


Manufactured by: Catalent, Woodstock, IL 60098 Distributed by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505


DYM:6987:50C:R2




Sodium Chloride Inhalation Solution 3% 15 mL


PRODUCT CODE 0378-6997-89


Sodium Chloride

Inhalation Solution, USP

Sterile, Non-pyrogenic,

Preservative-free, Single-use Vials


3% 15mL


For Respiratory Therapy


Not for parenteral administration.


15 mL, 50 Vials

Sterile

Unit-Dose Vial


Sodium Chloride Inhalation Solution, USP

3% 15 mL


Sterile, non-pyrogenic, preservative-free single-use vials for respiratory therapy.


INDICATIONS: Contents of these vials are for use in the induction of sputum production where specimen collection is indicated.


WARNING: Not for injection or in preparations to be used for injection.


DIRECTIONS FOR USE: To verify container integrity, squeeze the vial before use. Twist cap completely off vial, invert and squeeze prescribed volume.


Discard any unused portion of the contents of this single-use vial as well as any unused solution remaining in the nebulizer cup.


HOW SUPPLIED: Single-use plastic vials containing 15 mL solutions supplied in cartons of 50 vials.


PRODUCT CODE 0378-6997-89 Sodium Chloride Inhalation Solution USP 3%, 15 mL

PRODUCT CODE 0378-6998-89 Sodium Chloride Inhalation Solution USP 10%, 15 mL


Internal contents sterile. External surface of vial not sterile.


STORAGE: Store at controlled room temperature 15° to 30°C (59° to 86°F).


CAUTION: Federal law restricts this device to sale by or on the order of a Physician.


Manufactured by: The Ritedose Corporation, Columbia, SC 29203 Distributed by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505


DYM:6997:50C:RD:R1




Sodium Chloride Inhalation Solution 10% 15 mL


PRODUCT CODE 0378-6998-89


Sodium Chloride

Inhalation Solution, USP


Sterile, Non-pyrogenic,

Preservative-free, Single-use Vials

10% 15 mL


For Respiratory Therapy


Not for parenteral administration.


15 mL, 50 Vials

Sterile

Unit-Dose Vial


Sodium Chloride Inhalation Solution, USP

10% 15 mL


Sterile, non-pyrogenic, preservative-free single use vials for respiratory therapy.


INDICATIONS: Contents of these vials are for use in the induction of sputum production where specimen collection is indicated.


WARNING: Not for injection or in preparations to be used for injection.


DIRECTIONS FOR USE: To verify container integrity, squeeze the vial before use. Twist cap completely off vial. Invert and squeeze prescribed volume.


Discard any unused portion of the contents of this single-use vial as well as any unused solution remaining in the nebulizer cup.


HOW SUPPLIED: Single-use plastic vials containing 15 mL solutions supplied in cartons of 50 vials.


PRODUCT CODE 0378-6997-89 Sodium Chloride Inhalation Solution USP 3%, 15 mL

PRODUCT CODE 0378-6998-89 Sodium Chloride Inhalation Solution USP 10%, 15 mL


Internal contents sterile. External surface of vial not sterile.


STORAGE: Store at controlled room temperature 15° to 30°C (59° to 86°F).


CAUTION: Federal law restricts this device to sale by or on the order of a Physician.


Manufactured by: The Ritedose Corporation, Columbia, SC 29203 Distributed by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505


DYM:6998:50C:RD:R1










SODIUM CHLORIDE 
sodium chloride  solution










Product Information
Product TypeNDC Product Code (Source)0378-6985
Route of AdministrationRESPIRATORY (INHALATION)DEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (SODIUM CATION)SODIUM CHLORIDE0.027 mg  in 3 mL





Inactive Ingredients
Ingredient NameStrength
No Inactive Ingredients Found


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
10378-6985-01100 VIAL In 1 CARTONcontains a VIAL
13 mL In 1 VIALThis package is contained within the CARTON (0378-6985-01)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other03/24/2010







SODIUM CHLORIDE 
sodium chloride  solution










Product Information
Product TypeNDC Product Code (Source)0378-6986
Route of AdministrationRESPIRATORY (INHALATION)DEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (SODIUM CATION)SODIUM CHLORIDE0.045 mg  in 5 mL





Inactive Ingredients
Ingredient NameStrength
No Inactive Ingredients Found


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
10378-6986-01100 VIAL In 1 CARTONcontains a VIAL
15 mL In 1 VIALThis package is contained within the CARTON (0378-6986-01)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other03/24/2010







SODIUM CHLORIDE 
sodium chloride  solution










Product Information
Product TypeNDC Product Code (Source)0378-6987
Route of AdministrationRESPIRATORY (INHALATION)DEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (SODIUM CATION)SODIUM CHLORIDE0.135 mg  in 15 mL





Inactive Ingredients
Ingredient NameStrength
No Inactive Ingredients Found


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
10378-6987-8950 VIAL In 1 CARTONcontains a VIAL
115 mL In 1 VIALThis package is contained within the CARTON (0378-6987-89)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other03/24/2010







SODIUM CHLORIDE 
sodium chloride  solution










Product Information
Product TypeNDC Product Code (Source)0378-6997
Route of AdministrationRESPIRATORY (INHALATION)DEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (SODIUM CATION)SODIUM CHLORIDE0.45 mg  in 15 mL





Inactive Ingredients
Ingredient NameStrength
No Inactive Ingredients Found


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
10378-6997-8950 VIAL In 1 CARTONcontains a VIAL
115 mL In 1 VIALThis package is contained within the CARTON (0378-6997-89)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other03/24/2010







SODIUM CHLORIDE 
sodium chloride  solution










Product Information
Product TypeNDC Product Code (Source)0378-6998
Route of AdministrationRESPIRATORY (INHALATION)DEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SODIUM CHLORIDE (SODIUM CATION)SODIUM CHLORIDE1.5 mg  in 15 mL





Inactive Ingredients
Ingredient NameStrength
No Inactive Ingredients Found


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
10378-6998-8950 VIAL In 1 CARTONcontains a VIAL
115 mL In 1 VIALThis package is contained within the CARTON (0378-6998-89)










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other03/24/2010


Labeler - Mylan Pharmaceuticals Inc. (059295980)

Registrant - Mylan Pharmaceuticals Inc. (059295980)
Revised: 03/2010Mylan Pharmaceuticals Inc.




More Sodium Chloride Inhalation Solution resources


  • Sodium Chloride Inhalation Solution Drug Interactions
  • Sodium Chloride Inhalation Solution Support Group
  • 0 Reviews for Sodium Chloride - Add your own review/rating


Compare Sodium Chloride Inhalation Solution with other medications


  • Postural Orthostatic Tachycardia Syndrome

Numzident


Generic Name: benzocaine topical (BENZ oh kane TOP ik al)

Brand Names: Americaine, Americaine Hemorrhoidal, Anacaine, Anbesol Gel, Anbesol Liquid, Babee Teething Lotion, Benzo-O-Stetic, Boil Ease Pain Relieving, Cepacol Extra Strength, Cepacol Fizzlers, Dent-O-Kain, Dermoplast, Detane, Hurricaine, Lanacane, Maintain, Medicone Maximum Strength, Num-Zit, Numzident, Orabase, Orabase Gel-B, Orajel, Orajel Denture, Oral Pain Relief, OraMagic Plus, Outgro Pain Relief, Retre-Gel, Rid-A-Pain, Skeeter Stik, Solarcaine Aerosol, Sting-Kill, Topex, Trocaine, Vagisil Feminine Cream, zilactin-B


What is Numzident (benzocaine topical)?

Benzocaine is a local anesthetic (numbing medication). It works by blocking nerve signals in your body.


Benzocaine topical is used to reduce pain or discomfort caused by minor skin irritations, sore throat, sunburn, teething pain, vaginal or rectal irritation, ingrown toenails, hemorrhoids, and many other sources of minor pain on a surface of the body. Benzocaine is also used to numb the skin or surfaces inside the mouth, nose, throat, vagina, or rectum to lessen the pain of inserting a medical instrument such as a tube or speculum.


There are many brands and forms of benzocaine topical available and not all brands are listed on this leaflet.


Benzocaine topical may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Numzident (benzocaine topical)?


There are many brands and forms of benzocaine topical available and not all brands are listed on this leaflet.


Benzocaine topical used in the mouth or throat may cause a life-threatening condition in which the amount of oxygen in your blood stream becomes dangerously low. This condition is called methemoglobinemia (met-HEEM-oh glo-bin-EE-mee-a) and it may occur after only one use of benzocaine or after several uses.

Signs and symptoms of methemoglobinemia may occur within minutes or up to 2 hours after using benzocaine topical in the mouth or throat. GET EMERGENCY MEDICAL HELP IF YOU HAVE ANY OF THESE SYMPTOMS: headache, tired feeling, confusion, fast heart rate, and feeling light-headed or short of breath, with a pale, blue, or gray appearance of your skin, lips, or fingernails.


Do not use benzocaine topical if you have ever had methemoglobinemia in the past. Do not use this medicine on a child younger than 2 years old without medical advice. An overdose of numbing medications can cause fatal side effects if too much of the medicine is absorbed through your skin and into your blood. This is more likely to occur when using a numbing medicine without the advice of a medical doctor (such as during a cosmetic procedure like laser hair removal). Overdose symptoms may include uneven heartbeats, seizure (convulsions), coma, slowed breathing, or respiratory failure (breathing stops).

Use the smallest amount of this medication needed to numb the skin or relieve pain. Do not use large amounts of benzocaine topical, or cover treated skin areas with a bandage or plastic wrap without medical advice. Be aware that many cosmetic procedures are performed without a medical doctor present.


Your body may absorb more of this medication if you use too much, if you apply it over large skin areas, or if you apply heat, bandages, or plastic wrap to treated skin areas. Skin that is cut or irritated may also absorb more topical medication than healthy skin.

Before using benzocaine topical, tell your doctor if you have any type of inherited enzyme deficiency, heart disease, a breathing disorder such as asthma, bronchitis, or emphysema, or if you smoke.


If you are treating a sore throat, call your doctor if the pain is severe or lasts longer than 2 days, especially if you also develop a fever, headache, skin rash, swelling, nausea, vomiting, cough, or breathing problems.


What should I discuss with my health care provider before using Numzident (benzocaine topical)?


Do not use benzocaine topical if you have ever had methemoglobinemia in the past. An overdose of numbing medications can cause fatal side effects if too much of the medicine is absorbed through your skin and into your blood. This is more likely to occur when using a numbing medicine without the advice of a medical doctor (such as during a cosmetic procedure like laser hair removal). Overdose symptoms may include uneven heartbeats, seizure (convulsions), coma, slowed breathing, or respiratory failure (breathing stops).

Ask a doctor or pharmacist if it is safe for you to take this medicine if you have:



  • asthma, bronchitis, emphysema, or other breathing disorder;




  • heart disease;




  • a personal or family history of methemoglobinemia, or any genetic (inherited) enzyme deficiency; or




  • if you smoke.




FDA pregnancy category C. It is not known whether benzocaine topical will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.. It is not known whether benzocaine topical passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Do not use this medicine on a child younger than 2 years old without medical advice.

How should I use Numzident (benzocaine topical)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.


Your body may absorb more of this medication if you use too much, if you apply it over large skin areas, or if you apply heat, bandages, or plastic wrap to treated skin areas. Skin that is cut or irritated may also absorb more topical medication than healthy skin.

Use the smallest amount of medicine needed to numb the skin or relieve pain. Do not use large amounts of benzocaine topical, or cover treated skin areas with a bandage or plastic wrap without medical advice. Be aware that many cosmetic procedures are performed without a medical doctor present.


This medication comes with instructions for safe and effective application. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.


To treat minor skin conditions, apply a thin layer of benzocaine topical to the affected area up to 4 times per day. If using the spray, hold the container 6 to 12 inches away from the skin. Do not spray this medication onto your face. Spray it instead on your hands and then rub it onto the face, avoiding contact with your eyes.


To treat hemorrhoids, clean the area with soap and water before applying benzocaine topical. Apply the medication up to 6 times per day. If you are using the rectal suppository, try to empty your bowel and bladder before inserting the suppository. Remove the outer wrapper from the suppository before inserting it. Avoid handling the suppository too long or it will melt in your hands.


Do not use benzocaine topical to treat large skin areas or deep puncture wounds. Avoid using the medicine on skin that is raw or blistered, such as a severe burn or abrasion.

Call your doctor if your symptoms do not improve or if they get worse within the first 7 days of using benzocaine topical. Also call your doctor if your symptoms had cleared up but then came back.


If you are treating a sore throat, call your doctor if the pain is severe or lasts longer than 2 days, especially if you also develop a fever, headache, skin rash, swelling, nausea, vomiting, cough, or breathing problems.


Store at room temperature away from moisture and heat. Do not freeze.

What happens if I miss a dose?


Since benzocaine topical is used as needed, you may not be on a dosing schedule. If you are using the medication regularly, use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. An overdose of benzocaine topical applied to the skin can cause life-threatening side effects such as uneven heartbeats, seizure (convulsions), coma, slowed breathing, or respiratory failure (breathing stops).

What should I avoid while taking Numzident (benzocaine topical)?


Avoid eating within 1 hour after using benzocaine topical on your gums or inside your mouth.


Benzocaine topical is for use only on the surface of your body, or just inside the mouth, vagina, or rectum. Avoid getting this medication in your eyes. Avoid swallowing the gel, liquid, or ointment while applying it to your gums or the inside of your mouth. The throat spray or oral lozenge may be swallowed gradually during use.

Do not apply other medications to the same affected areas you treat with benzocaine topical, unless your doctor has told you otherwise.


Numzident (benzocaine topical) side effects


Benzocaine topical used in the mouth or throat may cause a life-threatening condition in which the amount of oxygen in your blood stream becomes dangerously low. This condition is called methemoglobinemia (met-HEEM-oh glo-bin-EE-mee-a) and it may occur after only one use of benzocaine or after several uses.

Signs and symptoms may occur within minutes or up to 2 hours after using benzocaine topical in the mouth or throat. GET EMERGENCY MEDICAL HELP IF YOU HAVE:



  • headache, tired feeling, confusion;




  • fast heart rate;




  • feeling light-headed or short of breath; and




  • pale, blue, or gray appearance of your skin, lips, or fingernails.




Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using benzocaine topical and call your doctor at once if you have any of these other serious side effects:

  • headache, weakness, dizziness, breathing problems, fast heart rate, and gray or bluish colored skin (rare but serious side effects of benzocaine);




  • severe burning, stinging, or sensitivity where the medicine is applied;




  • swelling, warmth, or redness; or




  • oozing, blistering, or any signs of infection.



Less serious side effects may include:



  • mild stinging, burning, or itching where the medicine is applied;




  • skin tenderness or redness; or




  • dry white flakes where the medicine was applied.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Numzident (benzocaine topical)?


It is not likely that other drugs you take orally or inject will have an effect on topically applied benzocaine topical. But many drugs can interact with each other. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Numzident resources


  • Numzident Side Effects (in more detail)
  • Numzident Use in Pregnancy & Breastfeeding
  • Numzident Support Group
  • 0 Reviews for Numzident - Add your own review/rating


  • Americaine Ointment MedFacts Consumer Leaflet (Wolters Kluwer)

  • Anacaine Advanced Consumer (Micromedex) - Includes Dosage Information

  • Anbesol Extra Strength Advanced Consumer (Micromedex) - Includes Dosage Information

  • Benz-O-Sthetic Gel MedFacts Consumer Leaflet (Wolters Kluwer)

  • Lanacane Aerosol Spray MedFacts Consumer Leaflet (Wolters Kluwer)

  • OraMagic Plus Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

  • Rid-A-Pain Topical Advanced Consumer (Micromedex) - Includes Dosage Information



Compare Numzident with other medications


  • Oral and Dental Conditions


Where can I get more information?


  • Your pharmacist can provide more information about benzocaine topical.

See also: Numzident side effects (in more detail)


Monday, 6 August 2012

Adrenaclick


Generic Name: epinephrine (Injection route)

ep-i-NEF-rin

Commonly used brand name(s)

In the U.S.


  • Adrenaclick

  • Adrenalin

  • Adrenalin Chloride

  • Epipen

  • Epipen Jr

  • Twinject

Available Dosage Forms:


  • Injectable

  • Solution

Therapeutic Class: Anaphylaxis Agent


Pharmacologic Class: Adrenergic


Chemical Class: Alkylarylamine


Uses For Adrenaclick


Epinephrine injection is used for emergency treatment of severe allergic reactions (including anaphylaxis) to insect bites or stings, medicines, foods, or other substances. It is also used to treat anaphylaxis caused by unknown substances or triggered by exercise.


This medicine is available only with your doctor's prescription.


Before Using Adrenaclick


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


No information is available on the relationship of age to the effects of epinephrine injection in the pediatric population. Safety and efficacy have not been established.


Geriatric


No information is available on the relationship of age to the effects of epinephrine injection in geriatric patients. However, elderly patients are more likely to have age-related heart disease which may require caution in patients receiving epinephrine injection.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Dihydroergotamine

  • Isocarboxazid

  • Linezolid

  • Phenelzine

  • Tranylcypromine

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Amitriptyline

  • Amoxapine

  • Bucindolol

  • Carteolol

  • Carvedilol

  • Clomipramine

  • Desipramine

  • Dilevalol

  • Dothiepin

  • Doxepin

  • Entacapone

  • Halothane

  • Imipramine

  • Levobunolol

  • Lofepramine

  • Metipranolol

  • Nadolol

  • Nortriptyline

  • Opipramol

  • Oxprenolol

  • Penbutolol

  • Pindolol

  • Propranolol

  • Protriptyline

  • Rasagiline

  • Sotalol

  • Tertatolol

  • Timolol

  • Trimipramine

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Labetalol

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Angina pectoris (severe chest pain) or

  • Blood vessel problems or

  • Diabetes mellitus (sugar diabetes) or

  • Heart attack or

  • Heart disease or

  • Heart rhythm problems or

  • Hypertension (high blood pressure) or

  • Overactive thyroid or

  • Parkinson's disease—Use with caution. May make these conditions worse.

Proper Use of epinephrine

This section provides information on the proper use of a number of products that contain epinephrine. It may not be specific to Adrenaclick. Please read with care.


Use this medicine only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.


If you are using this medicine at home, make sure you or any of your family members understand exactly how to give them. Also, tell your doctor if you or your caregiver has severe arthritis of the hands. If you have any questions about this, check with your doctor.


This medicine is injected under your skin or into the muscle of your outer thigh only. Do not inject this medicine into a vein or into the muscle of your buttocks. To do so, may increase the chance of having serious side effects.


This medicine comes with patient instructions. Read and follow these instructions carefully. Ask your doctor if you have any questions.


This medicine comes in an auto-injector syringe and needle kit that contains the correct dose of medicine your doctor has prescribed.


You may need to use more than one injection if your allergic reaction does not get better after the first shot.


Carry this medicine with you at all times for emergency use in case you have a severe allergic reaction.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For injection dosage form:
    • For allergic reactions:
      • Adults and children weighing above 30 kilograms (66 pounds)—0.3 milligram (mg) injected under the skin or into the muscle of your thigh.

      • Adults and children weighing 15 to 30 kilograms (33 to 66 pounds)—0.15 milligram (mg) injected under the skin or into the muscle of your thigh.



Storage


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Store the injection kits at room temperature, away from heat, moisture, and direct light. Do not store the medicine in the refrigerator or freezer. Keep the auto-injector in its case or tube.


Check the injection kits regularly to make sure that the liquid has not changed its color. Do not use this medicine if the liquid has changed its color, or if there are solids in the liquid.


Do not reuse the remaining portion of the medicine that is left in the auto-injector. Throw away the auto-injector after you have used it.


Precautions While Using Adrenaclick


If your symptoms do not improve within a few days or if they become worse, check with your doctor.


Anaphylaxis is a life-threatening reaction and requires immediate medical attention. Check with your doctor right away, or go to an emergency room as soon as possible, even if you feel better after using this medicine.


This medicine may affect blood sugar levels. If you notice a change in the results of your blood or urine sugar tests or if you have any questions, check with your doctor.


Do not inject this medicine into your hands or feet. There is already less blood flow to the hands and feet, and epinephrine could make that worse and cause damage to these tissues. If you accidentally inject epinephrine into your hands or feet, check with your doctor or go to the hospital emergency room right away.


Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.


Adrenaclick Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


Incidence not known
  • Abnormal or decreased touch sensation

  • arm, back or jaw pain

  • bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site

  • blurred vision

  • chest pain or discomfort

  • chest tightness or heaviness

  • dizziness

  • fainting fast, irregular, pounding, or racing heartbeat or pulse

  • fear or nervousness

  • headache

  • nausea or vomiting

  • paleness of the skin

  • pounding in the ears

  • restlessness

  • shakiness in the legs, arms, hands, or feet

  • shortness of breath

  • slow or fast heartbeat

  • stroke

  • sweating

  • trembling or shaking of the hands or feet

  • troubled breathing

  • unusual tiredness or weakness

  • wheezing

Get emergency help immediately if any of the following symptoms of overdose occur:


Symptoms of overdose
  • Agitation

  • coldness of the skin

  • coma

  • confusion

  • decreased urine output

  • depression

  • drowsiness

  • hostility

  • irritability

  • lethargy

  • lightheadedness, dizziness, or fainting

  • muscle twitching

  • pounding, slow heartbeat

  • rapid weight gain

  • rapid, deep breathing

  • seizures

  • stomach cramps

  • stupor

  • swelling of the face, ankles, or hands

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Adrenaclick side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Adrenaclick resources


  • Adrenaclick Side Effects (in more detail)
  • Adrenaclick Use in Pregnancy & Breastfeeding
  • Adrenaclick Drug Interactions
  • Adrenaclick Support Group
  • 0 Reviews for Adrenaclick - Add your own review/rating


  • Adrenaclick Prescribing Information (FDA)

  • Adrenaclick Auto-Injector MedFacts Consumer Leaflet (Wolters Kluwer)

  • Adrenaclick Concise Consumer Information (Cerner Multum)

  • Asthmahaler Aerosol MedFacts Consumer Leaflet (Wolters Kluwer)

  • Epinephrine Professional Patient Advice (Wolters Kluwer)

  • Epinephrine Monograph (AHFS DI)

  • Epinephrine (Mydriatic) eent Monograph (AHFS DI)

  • Medihaler-Epi Prescribing Information (FDA)

  • Twinject Auto-Injector Prescribing Information (FDA)



Compare Adrenaclick with other medications


  • Adams-Stokes Syndrome
  • Allergic Reactions
  • Asthma, acute
  • Asystole
  • AV Heart Block
  • COPD, Acute
  • Electromechanical Dissociation
  • Shock

Sunday, 5 August 2012

Codrix




Generic Name: acetaminophen and codeine phosphate

Dosage Form: tablets

Rx Only



Codrix Description


Acetaminophen and codeine is supplied in tablet form for oral administration.


Acetaminophen, 4'-hydroxyacetanalide, a slightly bitter, white, odorless, crystalline powder, is a non-opiate, non-salicylate analgesic and antipyretic. It has the following structural formula:



Codeine phosphate, 7,8-didehydro-4,5α-epoxy-3-methoxy-17-methylmorphinan-6α-ol phosphate (1:1) (salt) hemihydrate, a white crystalline powder, is a narcotic analgesic and antitussive. It has the following structural formula:



Each tablet contains:


Acetaminophen 500 mg


Codeine phosphate 15 mg


In addition each tablet contains the following inactive ingredients: Colloidal silicon dioxide, crospovidone, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch and stearic acid.



Codrix - Clinical Pharmacology


This product combines the analgesic effects of a centrally acting analgesic, codeine, with the peripherally acting analgesics, acetaminophen.



Pharmacokinetics


The behavior of the individual components is described below.



Codeine: Codeine is readily absorbed from the gastrointestinal tract. It is rapidly distributed from the intravascular spaces to the various body tissues, with preferential uptake by parenchymatous organs such as the liver, spleen and kidney. Codeine crosses the blood-brain barrier, and is found in fetal tissue and breast milk. The plasma concentration does not correlate with brain concentration or relief of pain; however, codeine is not bound to plasma proteins and does not accumulate in body tissues.


The plasma half-life is about 2.9 hours. The elimination of codeine is primarily via the kidneys, and about 90% of an oral dose is excreted by the kidneys within 24 hours of dosing. The urinary secretion products consist of free and glucuronide conjugated codeine (about 70%), free and conjugated norcodeine (about 10%), free and conjugated morphine (about 10%), normorphine (4%), and hydrocodone (1%). The remainder of the dose is excreted in the feces.


At therapeutic doses, the analgesic effect reaches a peak within 2 hours and persists between 4 and 6 hours.


See OVERDOSAGE for toxicity information.



Acetaminophen: Acetaminophen is rapidly absorbed from the gastrointestinal tract and is distributed throughout most body tissues. The plasma half-life is 1.25 to 3 hours, but may be increased by liver damage and following overdosage. Elimination of acetaminophen is principally by liver metabolism (conjugation) and subsequent renal excretion of metabolites. Approximately 85% of an oral dose appears in the urine within 24 hours of administration, most as the glucuronide conjugate, with small amounts of other conjugates and unchanged drug.


See OVERDOSAGE for toxicity information.



Indications and Usage for Codrix


Codrix™ is indicated for the relief of mild to moderately severe pain.



Contraindications


This product should not be administered to patients who have previously exhibited hypersensitivity to codeine or acetaminophen.



Warnings


In the presence of head injury or other intracranial lesions, the respiratory depressant effects of codeine and other narcotics may be markedly enhanced, as well as their capacity for elevating cerebrospinal fluid pressure. Narcotics also produce other CNS depressant effects, such as drowsiness, that may further obscure the clinical course of the patients with head injuries.


Codeine or other narcotics may obscure signs on which to judge the diagnosis or clinical course of patients with acute abdominal conditions.


Codeine is habit-forming and potentially abusable. Consequently, the extended use of this product is not recommended.



Precautions



General


Codrix™ should be prescribed with caution in certain special-risk patients, such as the elderly or debilitated, and those with severe impairment of renal or hepatic function, head injuries, elevated intracranial pressure, acute abdominal conditions, hypothyroidism, urethral stricture, Addison's disease, or prostatic hypertrophy.


Ultra-rapid Metabolizers of Codeine

Some individuals may be ultra-rapid metabolizers due to a specific CYP2D6*2x2 genotype. These individuals convert codeine into its active metabolite, morphine, more rapidly and completely than other people. This rapid conversion results in higher than expected serum morphine levels. Even at labeled dosage regiments, individuals who are ultra-rapid metabolizers may experience overdose symptoms such as extreme sleepiness, confusion or shallow breathing.


The prevalence of this CYP2D6 phenotype varies widely and has been estimated at 0.5 to 1% in Chinese and Japanese, 0.5 to 1% in Hispanics, 1-10% in Caucasians, 3% in African Americans, and 16-28% in North Africans, Ethiopians and Arabs. Data is not available for other ethnic groups.


When physicians prescribe codeine-containing drugs, they should choose the lowest effective dose for the shortest period of time and should inform their patients about these risks and the signs of morphine overdose. (See PRECATIONS-Nursing Mothers)



Information for Patients


Codeine may impair mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery. Such tasks should be avoided while taking this product.


Alcohol and other CNS depressants may produce an additive CNS depression, when taken with this combination product, and should be avoided.


Codeine may be habit-forming. Patients should take the drug only for as long as it is prescribed, in the amounts prescribed, and no more frequently than prescribed.


Caution patients that some people have a variation in a liver enzyme and change codeine into morphine more rapidly and completely than other people. These people are ultra-rapid metabolizers and are more likely to have higher-than-normal levels of morphine in their blood after taking codeine which can result in overdose symptoms such as extreme sleepiness, confusion, or shallow breathing. In most cases, it is unknown if someone is an ultra-rapid codeine metabolizer.


Nursing mothers taking codeine can also have higher morphine levels in their breast milk if they are ultra-rapid metabolizers. These higher levels of morphine in breast milk may lead to life threatening of fatal side effects in nursing babies. Instruct nursing mothers to watch for signs of morphine toxicity in their infants including increased sleepiness (more than usual), difficulty breastfeeding, breathing difficulties, or limpness. Instruct nursing mothers to talk to the baby's doctor immediately if they notice these signs and, if they cannot reach the doctor right away, to take the baby to an emergency room or call 911 (or local emergency services).



Laboratory Tests


In patients with severe hepatic or renal disease, effects of therapy should be monitored with serial liver and/or renal function tests.



Drug Interactions


This drug may enhance the effects of: other narcotic analgesics, alcohol, general anesthetic, tranquilizers such as chloridazepoxide, sedative-hypnotics, or other CNS depressants, causing increased CNS depression.



Drug/Laboratory Test Interactions


Codeine may increase serum amylase levels.


Acetaminophen may produce false-positive test results for urinary 5-hydroxyindoleacetic acid.



Carcinogenesis, Mutagenesis, Impairment of Fertility


No adequate studies have been conducted in animals to determine whether acetaminophen and codeine have a potential for carcinogenesis or mutagenesis. No adequate studies have been conducted in animals to determine whether acetaminophen has a potential for impairment of fertility.


Acetaminophen and codeine have been found to have no mutagenic potential using the Ames Salmonella-Microsomal Activation test, the Basc test on Drosophila germ cells, and the Micronucleus test on mouse bone marrow.



Pregnancy


Teratogenic Effects: Pregnancy Category C

Codeine: A study in rats and rabbits reported no teratogenic effect of codeine administered during the period of organogenesis in doses ranging from 5 to 120 mg/kg. In the rat, doses at the 120 mg/kg level, in the toxic range for the adult animal, were associated with an increase in embryo resorption at the time of implantation. In another study a single 100 mg/kg dose of codeine administered to pregnant mice reportedly resulted in delayed ossification in the offspring.


There are no adequate and well-controlled studies in pregnant women. Codrix™ should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.


Nonteratogenic Effects

Dependence has been reported in newborns whose mothers took opiates regularly during pregnancy. Withdrawal signs include irritability, excessive crying, tremors, hyperreflexia, fever, vomiting, and diarrhea. These signs usually appear during the first few days of life.



Labor and Delivery


Narcotic analgesics cross the placental barrier. The closer to delivery and the larger the dose used, the greater the possibility of respiratory depression in the newborn. Narcotic analgesics should be avoided during labor if delivery of a premature infant is anticipated. If the mother has received narcotic analgesics during labor, newborn infants should be observed closely for signs of respiratory depression. Resuscitation may be required (see OVERDOSAGE). The effect of codeine, if any, on the later growth, development, and functional maturation of the child is unknown.



Nursing Mothers


Codeine is secreted into human milk. In women with normal codeine metabolism (normal CYP2D6 activity), the amount of codeine secreted into human milk is low and dose-dependent. Despite the common use of codeine products to manage postpartum pain, reports of adverse events in infants are rare. However, some women are ultra-rapid metabolizers of codeine. These women achieve higher-than-expected serum levels of codeine's active metabolite, morphine, leading to higher-than-expected levels of morphine in breast milk and potentially dangerously high serum morphine levels in their breastfed infants. Therefore, maternal use of codeine can potentially lead to serious adverse reactions, including death, in nursing infants.


The prevalence of this CYP2D6 phenotype varies widely and has been estimated at 0.5 to 1% in Chinese and Japanese, 0.5 to 1% in Hispanics, 1-10% in Caucasians, 3% in African Americans, and 16-28% in North Africans, Ethiopians and Arabs. Data is not available for other ethnic groups.


The risk of infant exposure to codeine and morphine through breast milk should be weighed against the benefits of breastfeeding for both the mother and baby. Caution should be exercised when codeine is administered to a nursing woman. If a codeine containing product is selected, the lowest dose should be prescribed for the shortest period of time to achieve the desired clinical effect. Mothers using codeine should be informed about when to seek immediate medical care and how to identify the signs and symptoms of neonatal toxicity, such as drowsiness or sedation, difficulty breastfeeding, breathing difficulties, and decreased tone, in their baby. Nursing mothers who are ultra-rapid metabolizers may also experience overdose symptoms such as extreme sleepiness, confusion or shallow breathing. Prescribers should closely monitor mother-infant pairs and notify treating pediatricians about the use of codeine during breastfeeding. (See PRECAUTIONS - General- Ultra-rapid Metabolizers of Codeine)



Adverse Reactions


The most frequently reported adverse reactions are drowsiness, lightheadedness, dizziness, sedation, shortness of breath, nausea and vomiting. These effects seem to be more prominent in ambulatory than in non-ambulatory patients, and some of these adverse reactions may be alleviated if the patient lies down.


Other adverse drug reactions include allergic reactions, euphoria, dysphoria, constipation, abdominal pain, pruritus, rash, thrombocytopenia, agranulocytosis.


At higher doses codeine has most of the disadvantages of morphine including respiratory depression.



Drug Abuse and Dependence



Controlled Substance


Codrix™ is classified as a Schedule III controlled substance.



Abuse and Dependence


Codeine can produce drug dependence of the morphine type and, therefore, has the potential for being abused. Psychological dependence, physical dependence, and tolerance may develop upon repeated administration and it should be prescribed and administered with the same degree of caution appropriate to the use of other oral narcotic medications.



Overdosage


Following an acute overdosage, toxicity may result from codeine or acetaminophen.



Signs and Symptoms



Codeine: Toxicity from codeine poisoning includes the opioid triad of: pinpoint pupils, depression of respiration, and loss of consciousness. Convulsions may occur.



Acetaminophen: In acetaminophen overdosage: dose-dependent, potentially fatal hepatic necrosis is the most serious adverse effect. Renal tubular necrosis, hypoglycemic coma and thrombocytopenia may also occur.


Early symptoms following a potentially hepatotoxic overdose may include: nausea, vomiting, diaphoresis and general malaise. Clinical and laboratory evidence of hepatic toxicity may not be apparent until 48 to 72 hours post-ingestion.


In adults hepatic toxicity has rarely been reported with acute overdoses of less than 10 grams, or fatalities with less than 15 grams.



Treatment


A single or multiple overdose with acetaminophen and codeine is a potentially lethal polydrug overdose, and consultation with a regional poison control center is recommended.


Immediate treatment includes support of cardiorespiratory function and measures to reduce drug absorption. Vomiting should be induced mechanically, or with syrup of ipecac, if the patient is alert (adequate pharyngeal and laryngeal reflexes). Oral activated charcoal (1 g/kg) should follow gastric emptying. The first dose should be accompanied by an appropriate cathartic. If repeated doses are used, the cathartic might be included with alternate doses as required. Hypotension is usually hypovolemic and should respond to fluids. Vasopressors and other supportive measures should be employed as indicated. A cuffed endo-tracheal tube should be inserted before gastric lavage of the unconscious patient and, when necessary, to provide assisted respiration.


Meticulous attention should be given to maintaining adequate pulmonary ventilation. In severe cases of intoxication, peritoneal dialysis, or preferably hemodialysis may be considered. If hypoprothrombinemia occurs due to acetaminophen overdose, vitamin K should be administered intravenously.


Naloxone, a narcotic antagonist, can reverse respiratory depression and coma associated with opioid overdose. Naloxone hydrochloride 0.4 mg to 2 mg is given parenterally. Since the duration of action of codeine may exceed that of the naloxone, the patient should be kept under continuous surveillance and repeated doses of the antagonist should be administered as needed to maintain adequate respiration. A narcotic antagonist should not be administered in the absence of clinically significant respiratory or cardiovascular depression.


If the dose of acetaminophen may have exceeded 140 mg/kg, acetylcysteine should be administered as early as possible. Serum acetaminophen levels should be obtained, since levels fours or more hours following ingestion help predict acetaminophen toxicity. Do not await acetaminophen assay results before initiating treatment. Hepatic enzymes should be obtained initially, and repeated at 24-hour intervals.


Methemoglobinemia over 30% should be treated with methylene blue by slow intravenous administration.



Toxic Doses (for adults)


Acetaminophen: toxic dose 10 g


Codeine: toxic dose 240 mg



Codrix Dosage and Administration


Dosage should be adjusted according to severity of pain and response of the patient.


The usual adult dosage is:











Single Doses (range)Maximum 24 Hour Dose
Codeine Phosphate15 mg to 60 mg360 mg
Acetaminophen300 mg to 1000 mg4000 mg

The usual dose of codeine phosphate in children is 0.5 mg/kg.


Doses may be repeated up to every 4 hours.


The prescriber must determine the number of tablets per dose, and the maximum number of tablets per 24 hours based upon the above dosage guidance. This information should be conveyed in the prescription.


It should be kept in mind, however, that tolerance to codeine can develop with continued use and that the incidence of untoward effects is dose related. Adult doses of codeine higher than 60 mg fail to give commensurate relief of pain but merely prolong analgesia and are associated with an appreciably increased incidence of undesirable side effects. Equivalently high doses in children would have similar effects.



How is Codrix Supplied


Codrix™, (acetaminophen and codeine phosphate tablets, USP) 500 mg/15 mg are oval, white tablets with the “


Bottles of 100 Tablets        NDC 62022-711-01


Bottles of 500 Tablets        NDC 62022-711-05


Bottles of 1000 Tablets       NDC 62022-711-50


Store at controlled room temperature, 15 to 30°C (59 to 86°F) [see USP].


Dispense in tight, light-resistant container as defined in the USP.


Manufactured by:

Andrx Pharmaceuticals, Inc.

Fort Lauderdale, FL 33314


Manufactured for:

Andrx Laboratories, Inc.

Weston, FL 33331


Rev. date: 08/07

7210








Codrix 
acetaminophen and codeine phosphate  tablet










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)62022-711
Route of AdministrationORALDEA ScheduleCIII    



































INGREDIENTS
Name (Active Moiety)TypeStrength
acetaminophen (acetaminophen)Active500 MILLIGRAM  In 1 TABLET
codeine phosphate (codeine)Active15 MILLIGRAM  In 1 TABLET
Colloidal silicon dioxideInactive 
crospovidoneInactive 
croscarmellose sodiumInactive 
magnesium stearateInactive 
microcrystalline celluloseInactive 
povidoneInactive 
pregelatinized starchInactive 
stearic acidInactive 






















Product Characteristics
ColorWHITE (WHITE)Scoreno score
ShapeOVAL (Oval)Size18mm
FlavorImprint Code711
Contains      
CoatingfalseSymboltrue


















Packaging
#NDCPackage DescriptionMultilevel Packaging
162022-711-01100 TABLET In 1 BOTTLENone
262022-711-05500 TABLET In 1 BOTTLENone
362022-711-501000 TABLET In 1 BOTTLENone

Revised: 09/2007Andrx Laboratories, Inc.

More Codrix resources


  • Codrix Side Effects (in more detail)
  • Codrix Use in Pregnancy & Breastfeeding
  • Drug Images
  • Codrix Drug Interactions
  • Codrix Support Group
  • 28 Reviews for Codrix - Add your own review/rating


Compare Codrix with other medications


  • Cough
  • Osteoarthritis
  • Pain

Thursday, 2 August 2012

Calmurid Cream




UREA 10% LACTIC ACID 5%



Calmurid



1 0%/ 5% W/W CREAM




Calmurid 10%/ 5% w/w Cream



Urea 10% w/w



Lactic Acid 5% w/w




Read all of this leaflet carefully because it contains important information for you.



This medicine is available without prescription. However, you still need to use Calmurid carefully to get the best results from it.



  • Keep this leaflet. You may need to read it again.

  • Ask your pharmacist if you need more information or advice.

  • You must contact a doctor if your symptoms worsen or do not improve.

  • If any of the side effects gets serious, or if you notice any side effect not listed in this leaflet, please tell your doctor or pharmacist.




In this leaflet:



1. What Calmurid is and what it is used for

2. Before you use Calmurid

3. How to use Calmurid

4. Possible side effects

5. How to store Calmurid

6. Further information






What Calmurid is and what it is used for



  • Your doctor or pharmacist has recommended this cream for use as a moisturising cream for the treatment of dry, rough, scaly skin such as eczema and similar conditions.


  • The active substances in Calmurid are urea and lactic acid which act as moisturisers. This helps make your skin soft and supple.




Before you use Calmurid




Do not use Calmurid if you are:



  • Allergic (hypersensitive) to urea or lactic acid or any of the other ingredients of Calmurid. Please check by reading the list of ingredients in section 6. If you answer yes, you must inform your doctor before starting treatment.

Please seek immediate medical attention if you experience symptoms of an allergic reaction. Signs or symptoms of a severe
allergic reaction may include a rash, with or without itching, swelling of the face, eyelids or lips and difficulty in breathing.





Take special care with Calmurid



  • Avoid contact with the eyes, eyelids, lips and other mucous surfaces. Upon accidental contact, rinse the affected area with clean water.


  • Calmurid may cause stinging if applied to damaged skin (raw cracked areas or cracked skin) or sensitive areas of the body such as the mouth or nostrils.




Using other medicines



  • This cream might affect other medicines that you apply to your skin. Tell your doctor or pharmacist if you are using other medicines in this way.

Please tell your doctor or pharmacist if you are using or have recently used any other medicines, including medicines obtained without a prescription.





Pregnancy and breast-feeding



You should not use Calmurid and tell your doctor if you are pregnant, planning to become pregnant or are breast-feeding.



Your doctor will then decide whether you should use Calmurid.



Ask your doctor or pharmacist for advice before taking any medicine.



Please read the back of this leaflet






How to use Calmurid



Always use Calmurid exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.



  • Calmurid Cream is for EXTERNAL USE ONLY.


  • First gently wash and dry the affected areas of your skin.


  • Apply a thick layer over the affected areas. Do not rub it in yet.


  • Leave it on your skin for 3 to 5 minutes, then rub it in gently.


  • Wipe off any excess cream with a tissue (do not wash it off).


  • The cream should be used in this way twice a day, or as advised by your doctor.


  • If you need to use Calmurid on your feet, soak them in water for 15 minutes and then dry them with a rough towel before use.


  • How long you will have to use this product will depend on how quickly your condition improves. Always seek the advice of your doctor or pharmacist.


If you use more Calmurid than you should or accidentally swallow any of the cream



If you use too much Calmurid and stinging occurs, wash the cream off with water.



In the rare event that you accidentally swallow any of this product, seek medical advice.





If you forget to use Calmurid



Do not worry if you forget to use your cream at the right time. When you remember, start using the product again as you
did before.




If you have any further questions on the use of this product, ask your doctor or pharmacist.





Calmurid Cream Side Effects



Like all medicines, Calmurid can cause side effects, although not everybody gets them.




Effects on the skin



  • Calmurid may cause stinging if applied to raw areas or cracks in the skin or the lips.


  • Keep Calmurid away from other sensitive areas of your body.


  • If stinging occurs, wash the cream off with water.


  • Should stinging be a problem, you can mix it with an equal amount of Aqueous Cream BP (ask your pharmacist for this) for a week, after which it would be alright to use the cream on its own again, but you must consult your doctor
    or pharmacist first.



If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.





How to store Calmurid



  • Keep out of the reach and sight of children.


  • Do not use Calmurid after the expiry date which is stated on the tube and carton. The expiry date refers to the last day of that month.


  • Do not store above 25°C. Do not refrigerate or freeze.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines
no longer required. These measures will help to protect the environment.





Further information




What Calmurid contains



  • Calmurid contains the active substances urea 100mg/g and lactic acid 50mg/g.


  • The other ingredients are glyceryl monostearate, betaine monohydrate, diethanolamine cetyl phosphate, hard fat, cholesterol, sodium chloride and purified water.




What Calmurid looks like and contents of the pack



Calmurid is a white cream. It is available in 15 g, 20 g, 30 g, 50g and 100 g tubes and in 400 g and 500 g pump dispensers, either on prescription from your doctor or indirectly from your pharmacist.



Not all sizes of the tube may be marketed.





Marketing Authorisation Holder and Manufacturer



Marketing Authorisation Holder:




Galderma (UK) Limited

Meridien House

69-71 Clarendon Road

Watford

Herts

WD17 1DS

UK



Manufacturer:




Laboratoires Galderma

ZI-Montdésir

74540 Alby-sur-Chéran

France



Marketing Authorisation Numbers: PL 10590/0009 (UK), PA 590/8/1 (IRE)





This leaflet was last approved in 04/2009.





P20615-10







FUDR


Generic Name: floxuridine (Injection route)

flox-URE-i-deen

Injection route(Powder for Solution)

All patients should be hospitalized for initiation of the first course of therapy with floxuridine because of the possibility of severe toxic reactions .



Commonly used brand name(s)

In the U.S.


  • FUDR

Available Dosage Forms:


  • Powder for Solution

Therapeutic Class: Antineoplastic Agent


Pharmacologic Class: Antimetabolite


Uses For FUDR


Floxuridine belongs to the group of medicines known as antimetabolites. It is used to treat some kinds of cancer.


Floxuridine interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by floxuridine, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, like hair loss, may not be serious but may cause concern. Some effects may not occur for months or years after the medicine is used.


Before you begin treatment with floxuridine, you and your doctor should talk about the good this medicine will do as well as the risks of using it.


Floxuridine is to be administered only by or under the immediate supervision of your doctor.


Before Using FUDR


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


There is no specific information comparing use of floxuridine in children with use in other age groups.


Geriatric


Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. Although there is no specific information comparing use of floxuridine in the elderly with use in other age groups, this medicine is not expected to cause different side effects or problems in older people than it does in younger adults.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersDStudies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy in a life threatening situation or a serious disease, may outweigh the potential risk.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Rotavirus Vaccine, Live

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Adenovirus Vaccine Type 4, Live

  • Adenovirus Vaccine Type 7, Live

  • Bacillus of Calmette and Guerin Vaccine, Live

  • Influenza Virus Vaccine, Live

  • Measles Virus Vaccine, Live

  • Mumps Virus Vaccine, Live

  • Rotavirus Vaccine, Live

  • Rubella Virus Vaccine, Live

  • Smallpox Vaccine

  • Typhoid Vaccine

  • Varicella Virus Vaccine

  • Yellow Fever Vaccine

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Chickenpox (including recent exposure) or

  • Herpes zoster (shingles)—Risk of severe disease affecting other parts of the body

  • Hepatitis (history of)—Increased risk of hepatitis

  • Kidney disease or

  • Liver disease (other)—Effects of floxuridine may be increased because of slower removal from the body

  • Infection—Floxuridine can decrease your body's ability to fight infection

Proper Use of FUDR


Floxuridine sometimes causes nausea and vomiting. Tell your doctor if this occurs, especially if you have stomach pain.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


Precautions While Using FUDR


It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly and to check for unwanted effects.


While you are being treated with floxuridine, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's approval. Floxuridine may lower your body's resistance and there is a chance you might get the infection the immunization is meant to prevent. In addition, other persons living in your household should not take oral polio vaccine since there is a chance they could pass the polio virus on to you. Also, avoid persons who have recently taken oral polio vaccine. Do not get close to them and do not stay in the same room with them for very long. If you cannot take these precautions, you should consider wearing a protective face mask that covers the nose and mouth.


FUDR Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.



Check with your doctor immediately if any of the following side effects occur:


More common
  • Diarrhea

  • sores in mouth and on lips

  • stomach pain or cramps

Less common
  • Black, tarry stools

  • heartburn

  • nausea and vomiting

  • scaling or redness of hands or feet

  • swelling or soreness of the tongue

Rare
  • Blood in urine or stools

  • cough or hoarseness

  • fever or chills

  • lower back or side pain

  • painful or difficult urination

  • pinpoint red spots on skin

  • trouble in walking

  • unusual bleeding or bruising

  • yellow eyes or skin

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common or rare
  • Loss of appetite

  • skin rash or itching

This medicine sometimes causes temporary thinning of hair. After treatment with floxuridine has ended, normal hair growth should return.


Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: FUDR side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More FUDR resources


  • FUDR Side Effects (in more detail)
  • FUDR Use in Pregnancy & Breastfeeding
  • FUDR Drug Interactions
  • FUDR Support Group
  • 0 Reviews for FUDR - Add your own review/rating


  • FUDR Prescribing Information (FDA)

  • FUDR MedFacts Consumer Leaflet (Wolters Kluwer)

  • FUDR Concise Consumer Information (Cerner Multum)

  • Floxuridine Monograph (AHFS DI)

  • Floxuridine Prescribing Information (FDA)

  • Floxuridine Professional Patient Advice (Wolters Kluwer)



Compare FUDR with other medications


  • Liver Metastasis in Adenocarcinoma

Wednesday, 1 August 2012

clobazam


Generic Name: clobazam (KLOE ba zam)

Brand Names: Onfi


What is clobazam?

Clobazam is a benzodiazepine (ben-zoe-dye-AZE-eh-peen). Clobazam affects chemicals in the brain that may become unbalanced and cause anxiety.


Clobazam is used in combination with other medications to treat seizures caused by Lennox-Gastaut syndrome, a severe form of childhood epilepsy that also causes developmental and behavior problems.


Clobazam may also be used for purposes not listed in this medication guide.


What is the most important information I should know about clobazam?


You should not use clobazam if you are allergic to it.

Before taking clobazam, tell your doctor if you have kidney or liver disease, or a history of depression, suicidal thoughts, or addiction to drugs or alcohol.


You may have thoughts about suicide while taking this medication. Your doctor will need to check you at regular visits.


Report any new or worsening symptoms to your doctor, such as: mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), depressed, or have thoughts about suicide or hurting yourself. This medication may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert. Do not drink alcohol while taking clobazam. Clobazam may be habit-forming and should be used only by the person it was prescribed for. Keep the medication in a secure place where others cannot get to it.

What should I discuss with my healthcare provider before taking clobazam?


You should not take clobazam if you are allergic to it.

To make sure you can safely take clobazam, tell your doctor if you have any of these other conditions:



  • severe kidney disease;




  • liver disease;




  • a history of depression or suicidal thoughts or behavior; or




  • a history of drug or alcohol addiction.



You may have thoughts about suicide while taking this medication. Tell your doctor if you have new or worsening depression or suicidal thoughts during the first several months of treatment, or whenever your dose is changed.


Your family or other caregivers should also be alert to changes in your mood or symptoms. Your doctor will need to check you at regular visits. Do not miss any scheduled appointments.


Clobazam may be habit forming and should be used only by the person it was prescribed for. Never share clobazam with another person, especially someone with a history of drug abuse or addiction. Keep the medication in a place where others cannot get to it. FDA pregnancy category C. It is not known whether clobazam will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. Clobazam can make birth control pills less effective. Ask your doctor about using a non-hormone method of birth control (such as a condom, diaphragm, spermicide) to prevent pregnancy while taking clobazam. Clobazam can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. The sedative effects of clobazam may last longer in older adults. Accidental falls are common in elderly patients who take benzodiazepines. Use caution to avoid falling or accidental injury while you are taking clobazam. Clobazam should not be given to a child younger than 2 years old.

How should I take clobazam?


Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label. Your doctor may occasionally change your dose to make sure you get the best results.


You may crush the clobazam tablet and mix the medicine into a spoonful of applesauce to make swallowing easier. Swallow right away without chewing. Do not save the mixture for later use.


Do not stop using clobazam without first talking to your doctor, even if you feel fine. You may have increased seizures or unpleasant withdrawal symptoms if you stop using clobazam suddenly. You may need to use less and less before you stop the medication completely.

Use clobazam regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely. Contact your doctor if your seizures get worse or you have them more often while taking clobazam.


Store at room temperature away from moisture and heat.

Keep track of the amount of medicine used from each new bottle. Clobazam is a drug of abuse and you should be aware if anyone is using your medicine improperly or without a prescription.


See also: Clobazam dosage (in more detail)

What happens if I miss a dose?


Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. An overdose of clobazam can be fatal.

Overdose symptoms may include severe drowsiness, confusion, extreme weakness, fainting, and weak or shallow breathing.


What should I avoid while taking clobazam?


This medication may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert. Do not drink alcohol while taking clobazam.

Clobazam side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Report any new or worsening symptoms to your doctor, such as: mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), depressed, or have thoughts about suicide or hurting yourself. Stop using clobazam and call your doctor at once if you have a serious side effect such as:

  • confusion, hallucinations;




  • fever, chills, cough with yellow or green mucus, feeling short of breath;




  • feeling like you might pass out;




  • pain or burning when you urinate;




  • urinating less than usual or not at all; or




  • severe skin reaction -- fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain, followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling.



Less serious side effects may include:



  • drowsiness, dizziness;




  • feeling weak, tired, or irritable;




  • slurred speech, loss of balance or coordination;




  • appetite changes;




  • drooling;




  • sleep problems (insomnia);




  • constipation, vomiting, trouble swallowing;




  • mild fever;




  • dry cough.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


Clobazam Dosing Information


Usual Adult Dose for Lennox-Gastaut Syndrome:

Clobazam should be administered in divided doses twice daily (the 5 mg dose can be administered as a single daily dose). Dose escalation should not proceed more rapidly than every 7 days and dosing within each body weight group should be individualized.

Initial total daily dose:
Body weight 30 kg or less: 5 mg orally daily
Body weight 30 kg or more: 10 mg orally daily
Starting day 7 total daily dose:
Body weight 30 kg or less: 10 mg orally daily
Body weight 30 kg or more: 20 mg orally daily
Starting day 14 total daily dose:
Body weight 30 kg or less: 20 mg orally daily
Body weight 30 kg or more: 40 mg orally daily

Usual Geriatric Dose for Lennox-Gastaut Syndrome:

Initial dose: 5 mg orally daily
Maintenance dose: Dose should be initially titrated to 10 to 20 mg orally daily
Maximum dose: After the initial titration to 10 to 20 mg orally daily, the patient may be further titrated to the maximum dose (20 to 40 mg orally daily based on weight) may be started on day 21.

Usual Pediatric Dose for Lennox-Gastaut Syndrome:

Pediatric patients 2 years and greater:

Clobazam should be administered in divided doses twice daily (the 5 mg dose can be administered as a single daily dose). Dose escalation should not proceed more rapidly than every 7 days and dosing within each body weight group should be individualized.

Initial total daily dose:
Body weight 30 kg or less: 5 mg orally daily
Body weight 30 kg or more: 10 mg orally daily
Starting day 7 total daily dose:
Body weight 30 kg or less: 10 mg orally daily
Body weight 30 kg or more: 20 mg orally daily
Starting day 14 total daily dose:
Body weight 30 kg or less: 20 mg orally daily
Body weight 30 kg or more: 40 mg orally daily


What other drugs will affect clobazam?


Before using clobazam, tell your doctor if you regularly use other medicines that make you sleepy (such as cold or allergy medicine, other sedatives, narcotic pain medicine, sleeping pills, muscle relaxers, and medicine for seizures, depression, or anxiety). They can add to sleepiness caused by clobazam.

Tell your doctor about all other medicines you use, especially:



  • cimetidine (Tagamet);




  • fluvastatin (Lescol);




  • indomethacin (Indocin);




  • probenecid (Benemid);




  • ropinirole (Requip);




  • tamsulosin (Flomax);




  • terbinafine (Lamisil);




  • ticlopidine (Ticlid);




  • tolterodine (Detrol);




  • felbamate (Felbatol) or oxcarbazepine (Trileptal);




  • lansoprazole (Prevacid) or omeprazole (Prilosec);




  • ADHD medication such as atomoxetine (Strattera), dextroamphetamine (Adderall), methylphenidate (Ritalin, Daytana, Metadate, Concerta);




  • any type of antidepressant;




  • antifungal medication such as fluconazole (Diflucan), ketoconazole (Nizoral), or voriconazole (Vfend);




  • anti-malaria medication such as chloroquine (Aralen), pyrimethamine (Daraprim), or quinine (Qualaquin);




  • cancer medicine such as doxorubicin (Adriamycin, Doxil), gefitinib (Iressa), letrozole (Femara), lomustine (CeeNU), or tamoxifen (Soltamox);




  • cough medicine such as dextromethorphan (Robitussin Maximum Strength, Vicks 44, and others) or dihydrocodeine (Alahist DHC, J-Max DHC, Pancof-PD, Panlor, Trezix, Welltuss EXP, and others);




  • heart or blood pressure medication such as amiodarone (Cordarone, Pacerone), captopril (Capoten), flecainide (Tambocor), metoprolol (Lopressor, Toprol), nicardipine (Cardene), procainamide (Procan, Pronestyl), propafenone (Rythmol), propranolol (Inderal), quinidine (Quin-G), and others;




  • HIV/AIDS medication such as delavirdine (Rescriptor), efavirenz (Sustiva, Atripla), etravirine (Intelence), or ritonavir (Norvir, Kaletra);




  • medicine to treat psychiatric disorders, such as aripiprazole (Abilify), clozapine (Clozaril, FazaClo), haloperidol (Haldol), risperidone (Risperdal), and others; or




  • pain medicine such as codeine (Tylenol #3), hydrocodone (Lortab, Vicodin), oxycodone (OxyContin, Percocet), tramadol (Ultram, Ultracet), and others.



This list is not complete and other drugs may interact with clobazam. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More clobazam resources


  • Clobazam Side Effects (in more detail)
  • Clobazam Dosage
  • Clobazam Use in Pregnancy & Breastfeeding
  • Clobazam Drug Interactions
  • Clobazam Support Group
  • 0 Reviews for Clobazam - Add your own review/rating


  • clobazam Advanced Consumer (Micromedex) - Includes Dosage Information

  • Clobazam Professional Patient Advice (Wolters Kluwer)

  • Clobazam MedFacts Consumer Leaflet (Wolters Kluwer)

  • Onfi Consumer Overview



Compare clobazam with other medications


  • Lennox-Gastaut Syndrome


Where can I get more information?


  • Your pharmacist can provide more information about clobazam.

See also: clobazam side effects (in more detail)